CV NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

CapsoVision, Inc. Common Stock · Healthcare · Medical Devices

Open interactive chart View report data
Latest close 6.58 USD
1.4% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 3.8% above the Trend Line and sits at 26.4% of its 52-week range. The latest completed week returned 1.4%, after a -9.6% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is expensive relative to peers. The latest news-sentiment score is 53/100. Near-term considerations: volume confirmation is below normal; earnings are due in 11d.

Setup score 24 out of 100
Latest Close 6.58 USD 31 Jul 2026
1W Return 1.4% latest completed week
4W Return -9.6% short-term follow-through
12W Return -7.6% quarterly tape
Trend Breadth 7.7% 4 of 52 weeks active
Volume Ratio 0.6x vs 13-week average
What is working
  • The trend backdrop is active with a 2-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
What could go wrong
  • Activity pressure is negative, which weakens the current setup.
  • Next-week expectancy is negative at 20.61% based on similar historical setup states.
  • The share remains more than 20% below its 52-week high.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 1.4% Latest completed week; four-week move -9.6%. Indicator stack 11/14 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 20.61% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 53/100 46 relevant articles in the latest sentiment read. Event risk 11d Next report is scheduled for 13 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 3.8% above the Trend Line and sits at 26.4% of its 52-week range. The latest completed week returned 1.4%, after a -9.6% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.6x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.5012-week average 0.54

12-week confirmation

Trend active2/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure9/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership2/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.50Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -9.6% over four weeks, -7.6% over 12 weeks, and 68.3% over one year. The current trend has remained active for 2 consecutive weeks.

Performance by holding period

1W1.4%
4W-9.6%
12W-7.6%
26W31.1%
52W68.3%
Active trend streak2 weeks
Active weeks in one year4
Trend breadth7.7%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.47Latest activity-pressure read.
Pressure change-342.1%Four-week change in activity pressure.
Leadership-2.72Latest relative-leadership reading.
RS change-152.0%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 82% Model confidence 78%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength13/100Blend of value, momentum, and quality. Underlying universe rank 88; rank 1 is best.
Value13/100Relative valuation strength. Underlying universe rank 88; rank 1 is best.
Quality5/100Profitability and accounting quality. Underlying universe rank 96; rank 1 is best.
Momentum91/100Medium-term price momentum. Underlying universe rank 10; rank 1 is best.
Growth73/100Revenue and earnings growth. Underlying universe rank 28; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
23.9x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-7.8%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
51.7%
Gross profit retained from each unit of revenue.
Operating margin
-200.7%
Operating profit retained from revenue.
Free-cash-flow margin
-175.8%
Free cash flow generated from revenue.
Return on invested capital
-664.1%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
12.6%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
3/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-8.2%
Net share repurchases relative to market value.
Shareholder yield
-8.2%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.6x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment53/100

Weighted news tone is neutral across 46 relevant articles.

10 positive · 34 neutral · 2 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings11dNext report is scheduled for 13 Aug 2026; event risk rises as the date approaches.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-57.2%Distance below the 52-week high.
13-week volatility8.3%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher12 of 2613 weeks finished lower.
Best week+24.5%Week of 20 Mar.
Worst week-17.7%Week of 10 Jul.
Latest week+1.4%Week of 31 Jul.

Shape of recent returns

Strong gains8
Modest gains4
Flat weeks1
Modest losses7
Sharp losses6
Recent vol8.3%13-week weekly-return volatility.
Base vol16.3%52-week weekly-return volatility.
Up/down split26/25Count of positive and negative weeks in the 52-week window.
Average skew11.6% / -7.6%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape24/100

Trend, activity pressure, participation, and risk combine to a 24/100 tape read.

 Indicator analysis41/100

Latest 12-week confirmation: trend 2/12, activity pressure 9/12, relative leadership 2/12.

Activity pressure 0.50; No reversal markers Next-Week ExpectancyNegative 20.61%

Next-week expectancy is negative with a 20.61% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors27/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 85; Small Cap Core rank 92 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment53/100

Weighted news tone is neutral across 46 relevant articles.

CapsoVision to Release Second Quarter 2026 Financial Results on August 13, 2026 Insiders50/100

No recent insider transaction evidence is stored.

 Earnings11d

Next report is scheduled for 13 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 20266.58 USD1.4%6.34 USD6.05 USD-0.47-2.72389.3KOn
24 Jul 20266.49 USD-3.3%6.46 USD6.04 USD-0.29-3.05457.8KOn
17 Jul 20266.71 USD12.0%6.68 USD6.03 USD-0.05-0.90546.4KOff
10 Jul 20265.99 USD-17.7%6.90 USD6.02 USD0.02-14.961.0MOff
3 Jul 20267.28 USD-3.2%7.12 USD6.02 USD0.195.23711.2KOff
26 Jun 20267.52 USD13.8%7.11 USD6.00 USD0.2310.132.1MOff
19 Jun 20266.61 USD-8.1%7.05 USD5.97 USD0.18-810.6KOff
12 Jun 20267.19 USD0.0%7.00 USD5.95 USD0.22-552.8KOff
5 Jun 20267.19 USD6.0%6.93 USD5.93 USD0.19-710.2KOff
29 May 20266.78 USD2.1%6.85 USD5.90 USD0.18-332.2KOff
22 May 20266.64 USD2.9%6.79 USD5.88 USD0.21-452.8KOff
15 May 20266.46 USD-9.3%6.73 USD5.87 USD0.15-549.0KOff
8 May 20267.12 USD-5.1%6.67 USD5.85 USD0.09-411.5KOff
1 May 20267.50 USD23.6%6.59 USD5.83 USD-0.11-850.6KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.